Correlation Between Hanwha InvestmentSecuri and Bridge Biotherapeutics
Can any of the company-specific risk be diversified away by investing in both Hanwha InvestmentSecuri and Bridge Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hanwha InvestmentSecuri and Bridge Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Hanwha InvestmentSecurities Co and Bridge Biotherapeutics, you can compare the effects of market volatilities on Hanwha InvestmentSecuri and Bridge Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hanwha InvestmentSecuri with a short position of Bridge Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hanwha InvestmentSecuri and Bridge Biotherapeutics.
Diversification Opportunities for Hanwha InvestmentSecuri and Bridge Biotherapeutics
-0.62 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Hanwha and Bridge is -0.62. Overlapping area represents the amount of risk that can be diversified away by holding Hanwha InvestmentSecurities Co and Bridge Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bridge Biotherapeutics and Hanwha InvestmentSecuri is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hanwha InvestmentSecurities Co are associated (or correlated) with Bridge Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bridge Biotherapeutics has no effect on the direction of Hanwha InvestmentSecuri i.e., Hanwha InvestmentSecuri and Bridge Biotherapeutics go up and down completely randomly.
Pair Corralation between Hanwha InvestmentSecuri and Bridge Biotherapeutics
Assuming the 90 days trading horizon Hanwha InvestmentSecuri is expected to generate 1.48 times less return on investment than Bridge Biotherapeutics. But when comparing it to its historical volatility, Hanwha InvestmentSecurities Co is 1.55 times less risky than Bridge Biotherapeutics. It trades about 0.05 of its potential returns per unit of risk. Bridge Biotherapeutics is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 386,000 in Bridge Biotherapeutics on September 27, 2024 and sell it today you would earn a total of 19,000 from holding Bridge Biotherapeutics or generate 4.92% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Hanwha InvestmentSecurities Co vs. Bridge Biotherapeutics
Performance |
Timeline |
Hanwha InvestmentSecuri |
Bridge Biotherapeutics |
Hanwha InvestmentSecuri and Bridge Biotherapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Hanwha InvestmentSecuri and Bridge Biotherapeutics
The main advantage of trading using opposite Hanwha InvestmentSecuri and Bridge Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hanwha InvestmentSecuri position performs unexpectedly, Bridge Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bridge Biotherapeutics will offset losses from the drop in Bridge Biotherapeutics' long position.The idea behind Hanwha InvestmentSecurities Co and Bridge Biotherapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Bridge Biotherapeutics vs. KNOTUS CoLtd | Bridge Biotherapeutics vs. Cytogen | Bridge Biotherapeutics vs. Genolution | Bridge Biotherapeutics vs. WOOJUNG BIO |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Complementary Tools
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Transaction History View history of all your transactions and understand their impact on performance |